FAK regulates Cdk2 in EGF-stimulated primary cultures of hepatocytes

Liv Ingrid Flinder1, Lene Wierød, Carola M Rosseland

  • 1Laboratory for Toxicopathology, Institute of Pathology, Oslo University Hospital, University of Oslo, Oslo, Norway.

Insights

Focal adhesion kinase (FAK) regulates cell cycle entry by controlling Cdk2 levels in hepatocytes. This finding reveals FAK

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cellular processes like proliferation and motility depend on anchorage-dependent signaling.
  • Focal adhesion kinase (FAK) plays a role in cell signaling pathways.
  • Cyclin-dependent kinase 2 (Cdk2) is crucial for cell cycle progression.

Purpose of the Study:

  • To investigate the novel role of FAK in regulating Cdk2 in primary cultured hepatocytes.
  • To elucidate the mechanism by which FAK mediates Cdk2 regulation in response to growth factors.

Main Methods:

  • Utilized FAK inhibition and specific FAK mutants (FAKY397F, FAKY925F, FAKY861F) in primary cultured hepatocytes.
  • Assessed S-phase entry, protein expression, and nuclear accumulation of cell cycle regulators (Cdk2, cyclin E, p27, cyclin D1).
  • Investigated the impact of FAK on epidermal growth factor (EGF) and hepatocyte growth factor (HGF) signaling, including cell spreading and survival.

Main Results:

  • FAK inhibition reduced S-phase entry, Cdk2 expression, and nuclear accumulation in response to EGF.
  • FAK regulates Cdk2 levels, influencing the expression of its inhibitor p27.
  • Specific FAK phosphorylation sites are critical for EGF-induced ERK activity and Cdk2 expression, and FAK is essential for HGF-mediated proliferation and growth factor-induced cell spreading.

Conclusions:

  • FAK acts as a central coordinator of integrin and growth factor signaling for S-phase entry.
  • FAK regulates Cdk2, a key G1/S-phase transition regulator.
  • Integrins and growth factors cooperate through FAK in anchorage-dependent signaling pathways that control proliferation and motility.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...